C-C Wang - Liver Transplantation Program, Kaohsiung Chang Gung Memorial Hospital

基本信息

浏览量：16

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 424 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Amivantamab Plus Lazertinib Versus Osimertinib in First-Line EGFR-mutant Advanced Non-Small Cell Lung Cancer with Biomarkers of High-Risk Disease: a Secondary Analysis from MARIPOSA

E. Felip,B. C. Cho,V Gutierrez,A. Alip,B. Besse,S. Lu,A. I. Spira,N. Girard,R. Califano,S. M. Gadgeel,J. C-H. Yang,S. Yamamoto,K. Azuma,Y. J. Kim,K. -H. Lee,P. Danchaivijitr, C. G. Ferreira,Y. Cheng,M. A. N. Sendur,G. -C. Chang,C. -C. Wang,K. Prabhash,Y. Shinno,D. Stroyakovskiy,L. Paz-Ares, J. R. Rodriguez-Cid, C. Martin, M. R. G. Campelo,H. Hayashi,D. Nguyen,P. Tomasini,M. Gottfried,C. Dooms,A. Passaro,M. Schuler, A. C. Z. Gelatti,S. Owen,K. Perdrizet,S. -H. I. Ou,J. C. Curtin, J. Zhang, M. Gormley,T. Sun, A. Panchal, M. Ennis,E. Fennema,J. M. Bauml, M. Daksh, S. Sethi,S. -H. Lee

ANNALS OF ONCOLOGYno. 9 (2024): 805-816

引用5浏览0WOS引用

Reconstruction of hepatic vein by using falciform ligament in living donor liver transplantation

T. Y. Hou,Y. C. Lin,K. C. Hung,W. F. Li,C. C. Lin,T. S. Lin,C. C. Wang

TRANSPLANTATION（2023）

引用0浏览0引用

Bloodstream infections after liver transplantation: risk factors and outcomes

C. -C. Wang, T. -Y. Hou, I. -K. Lee,P. -H. Chang,Y. -C. Lin,K. -C. Hung,W. -F. Li,C. -H. Yeh, W. -J. Tzeng, H. -Y. Tseng,C. -C. Lin,T. -S. Lin

TRANSPLANTATIONno. 9 (2023): 290-290

引用0浏览0引用

Back-table portal vein and hepatic vein reconstruction by using autologous falciform ligament: video case sharing

Y. C. Lin,W. F. Li,K. C. Hung,T. S. Lin,C. C. Lin,C. C. Wang

TRANSPLANTATION（2023）

引用0浏览0引用

Effect of mechanical ventilation on postoperative outcomes of patients undergoing living donor liver transplantation

Y. -L. Liu,C. -L. Chen,C. -C. Wang,S. -H. Wang,C. -C. Lin,C. -C. Yong,Y. -W. Liu,Y. -H. Lin,W. -F. Li,Y. -C. Chan,K. -C. Hung,C. -H. Yeh, S. -M. Yin,Y. -C. Lin, W. -J. Tzeng

TRANSPLANTATION（2023）

引用0浏览0引用

The Real-World Effectiveness and Safety of Edoxaban Treatment in 27,333 Global ETNA-AF Programme Patients with and Without a History of Heart Failure

J. Siller-Matula,M. Unverdorben,C. -C. Wang,Y. Koretsune,L. Pecen,A. Borrow,C. Chen,P. Kirchhof,R. De Caterina

European Heart Journal（2022）

引用0浏览0引用

EP08.02-027 T790M Detection Rate after First-Line Treatment with Bevacizumab Plus 1st or 2nd Generation EGFR-TKI in Advanced NSCLC

C.-H. Kuo,P.-L. Su,Y.-F. Wei, J.-C. Ko,J.-S. Tseng, J. Su,C.-L. Chiang,C.-Y. Chen,C.-C. Lin,C.-C. Wang,C.-C. HO, H.C. Chang,J.-Y. Hung

Journal of thoracic oncologyno. 9 (2022): S409-S410

引用0浏览0引用

Two-year Effectiveness and Safety Outcomes in 27,333 Edoxaban-Treated Patients with and Without a History of Major Bleeding from the Global ETNA-AF Programme

V. Russo,C. -C. Wang,M. Unverdorben,T. Yamashita,L. Pecen,A. Borrow,C. Chen,P. Kirchhof,R. De Caterina

EUROPEAN HEART JOURNAL（2022）

引用0浏览0引用

Real-world Effectiveness and Safety of Edoxaban in Patients with and Without a History of Ischaemic Stroke: Results from the ETNA-AF Programme

R. De Caterina,M. Unverdorben,B-C Lee,T. Yamashita,W-S Lin,C-C Wang,L. Pecen,A. Borrow,C. Chen,P. Kirchhof

EUROPEAN HEART JOURNAL（2022）

引用0浏览0引用

HCV core antigen and residual HCV RNA in the native liver of living donor liver transplant recipients with chronic hepatitis C

S. -H. Lin,C. -C. Wang,C. -L. Chen,K. -T. Huang,K. -D. Chen,L. -W. Hsu,K. -W. Chiu

TRANSPLANTATION（2022）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn